5th AndroGel Bellwether Trial Ends In Defense Verdict For AbbVie, Abbott
CHICAGO — The fifth AndroGel multidistrict litigation bellwether trial ended June 14 with a verdict for defendants AbbVie Inc. and Abbott Laboratories (In Re: Testosterone Replacement Therapy Products Liability Litigation, MDL...To view the full article, register now.
Already a subscriber? Click here to view full article